Prediction of Abdominal Complications After GastroEnterological Surgery
NCT ID: NCT03828266
Last Updated: 2019-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2019-01-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Intra-abdominal Infectious Complication by Drainage Fluid Analysis
NCT03862378
Bacteriology of sUrGical Site INfection Following Surgery for Intestinal Failure
NCT05234515
Determining the Worldwide Epidemiology of Surgical Site Infections After Gastrointestinal Surgery
NCT02662231
Emergency General Surgery for Non-trauma
NCT04539028
The Impact of Laparoscopic Versus Open Surgeries on the Incidence of Postoperative Deep Vein Thrombosis in Patients With Gastrointestinal Malignancy ---A Cohort Study
NCT02297269
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The detailed registered information includes:
I. Basic and surgical information:
Age, height, weight, history of abdominal surgery, ASA score, surgical procedure, extent of lymph node dissection, extent of resection, time of surgery, amount of bleeding, whether it is emergency surgery, whether it is combined with organ resection, whether it is palliative resection, whether combined with preoperative treatment, whether combined with preoperative infection and intraoperative complications.
II. Postoperative information:
Primary lesion histological type, margin, pathological stage (pTNM); other complications, postoperative death and discharge time, CRP, PCT, WBC levels.
III. Abdominal Infection information:
Abdominal infection (Y/N), anastomotic leakage (Y/N), intervention, outcome.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Patients will undergo routine clinical practice. There is no additional intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Inform consent received.
Exclusion Criteria
* Inform consent denied.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ziyu Li, MD
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ziyu Li, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Peking University Cancer Hospital & Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Cancer Hospital
Beijing, Beijing Municipality, China
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Xiamen University First Hospital
Xiamen, Fujian, China
Guangdong People's Hospital
Guangzhou, Guangdong, China
The First Affilliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
South Hospital
Guanzhou, Guangdong, China
Nanchang University First Hospital
Nanchang, Jiangxi, China
Jilin University Second Hospital
Changchun, Jilin, China
Dalian Medical University First Hospital
Dalian, Liaoning, China
Qinghai University Affiliated Hospital
Xining, Qinghai, China
Shandong Provincial Hospital
Jinan, Shandong, China
Qingdao University Affiliated Hospital
Qingdao, Shandong, China
Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, China
Huashan Hospital
Shanghai, Shanghai Municipality, China
Ruijin Hospital
Shanghai, Shanghai Municipality, China
Zhongshan Hospital
Shanghai, Shanghai Municipality, China
Xi'an Jiao Tong University First Hospital
Xi’an, Shanxi, China
Hangzhou First Hospital
Hangzhou, Zhejiang, China
Run Run Shaw Hospital
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhaohui Zheng
Role: primary
Jun You
Role: primary
Yong Li
Role: primary
Zhengrong Li
Role: primary
Jiaming Zhu
Role: primary
Pin Liang
Role: primary
Changqing Jing
Role: primary
Zhaojian Niu
Role: primary
Hua Huang
Role: primary
Hankun Hao
Role: primary
Lu Zang
Role: primary
Fenglin Liu
Role: primary
Lin Fan
Role: primary
Jian Zhang
Role: primary
Linghua Zhu
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Wu Z, Gu T, Wang X, Wei T, Shan F, Li Z, Ji J; PACAGE study group. Surgical quality and health utilization of gastric cancer surgery in China: a post hoc analysis of the Prevalence of Abdominal Complications After Gastroenterological Surgery study. BMJ Surg Interv Health Technol. 2025 Jul 15;7(1):e000332. doi: 10.1136/bmjsit-2024-000332. eCollection 2025.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018YJZ56
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.